Shanghai Kehua Bio-engineering(002022) Key Financial Indicators

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

YOY

Do not show

Hide blank lines

(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30

Per Share Indicator

Net Asset Per Share

30.08% 9.1878 25.27% 9.0851 35.40% 9.5023 7.71% 7.0487

Basic Earning Per Share

145.96% 0.1065 14.09% 1.8878 63.39% 2.3178 -90.31% 0.0903

Diluted Earning Per Share

99.81% 0.1065 13.86% 1.8206 61.91% 2.2102 -87.72% 0.1102

Earning Per Share

145.96% 0.1065 14.16% 1.8877 63.62% 2.3177 -90.30% 0.0903

Diluted Earning Per Share（TTM）

89.15% 1.9509 14.16% 1.8877 31.10% 2.5536 -56.53% 0.8123

Capital Surplus Funds Per Share

-2.17% 0.5724 -0.54% 0.5724 -2.03% 0.5753 -0.43% 0.5842

Undivided Profit Per Share

42.61% 7.155 34.88% 7.0485 50.14% 7.4783 11.22% 4.9993

Operating Cash Flow Per Share

-3,344.08% -0.7948 99.55% 4.1875 92.32% 2.8656 -90.98% 0.0796

Enterprise FCF Per Share

-440.50% -1.029 94.26% 3.4666 126.10% 2.1075 -47.26% 0.4316

Shareholder FCF Per Share

-521.17% -1.0226 167.00% 3.3904 898.61% 2.0781 499.68% 0.37

EBIT Per Share

169.07% 0.254 24.84% 4.0072 56.93% 4.2569 -88.91% 0.1946

Profitability

ROE Weighted

91.53% 1.130% -7.49% 22.360% 17.40% 24.560% -91.31% 1.230%

ROE

90.58% 1.125% -8.19% 20.163% 22.06% 23.700% -90.97% 1.232%

ROA

121.48% 1.153% 4.89% 21.960% 30.40% 23.980% -91.22% 1.081%

ROIC

128.35% 1.640% 9.86% 27.276% 23.38% 26.945% -90.00% 1.454%

Net Profit Ratio

54.20% 11.664% -10.93% 24.841% 16.76% 35.892% -76.26% 7.336%

Gross Income Ratio

6.68% 46.883% -3.64% 52.557% -1.84% 57.001% -25.94% 43.277%

EBIT To Total Operating Revenue

35.74% 15.678% -13.05% 29.568% 8.59% 40.674% -70.54% 11.083%

Period Costs Rate

-3.35% 34.795% -0.83% 20.493% -28.57% 14.762% 68.74% 34.406%

Operating Expense Rate

-12.85% 15.422% 3.34% 10.981% -30.80% 8.502% 38.97% 16.858%

Admini Expense Rate

-8.50% 9.759% 16.71% 7.068% -7.56% 4.911% 103.25% 10.770%

Financial Expense Rate

-19.57% 1.714% -224.50% -1.150% -325.94% -1.579% 173.42% 2.201%

Recurrent Net Profit

130.37% 48.14M 13.88% 952.36M 63.65% 1.18B -90.53% 44.78M

Operating Profit Ratio

49.26% 14.053% -12.38% 29.630% 15.01% 42.278% -74.99% 9.341%

EBIT

168.94% 130.62M 24.84% 2.06B 56.81% 2.19B -88.92% 100.07M

Solvency

Current Ratio

-11.17% 4.1277 -35.09% 3.1393 -0.85% 5.3509 -18.47% 4.1053

Quick Ratio

0.12% 3.287 -37.01% 2.5225 0.11% 4.3692 -26.34% 2.8916

Debt Equity Ratio

34.95% 39.733% 42.35% 50.601% -2.22% 30.920% -8.08% 31.126%

Interest Cover（T）

68.76% 9.1483 -- -- -- -- -95.55% 6.2629

Shareholders Equity Without Minority Interests To Total Liabilities

-32.50% 212.808% -23.41% 162.603% -3.51% 232.528% 30.89% 299.551%

Shareholders Equity Without Minority Interests To Interest Bear Debt

22.36% 567.0153% 25.77% 574.6759% 21.10% 605.7698% -5.81% 457.266%

Long Debt To Working Capital

-54.01% 0.214 -5.09% 0.2067 -22.85% 0.1573 108.09% 0.4744

Growth Ability

Average Net Profit YOY Past Five Year

-12.45% 100.983% 6.76% 49.207% 71.40% 35.430% 273.49% 37.743%

Sustainable Grow Rate

145.73% 2.018% -26.34% 30.500% 36.75% 49.892% -92.75% 1.710%

Operating Capacity

Operating Cycle（D/T）

-10.56% 385.6483 -11.68% 172.6545 -12.51% 178.8394 91.55% 402.3984

Inventory Turnover Days（D/T）

-10.08% 245.9002 -11.86% 113.9359 -12.24% 121.751 71.05% 253.7757

Accounts Receivable Turnover Days（D/T）

-11.40% 139.7481 -11.32% 58.7186 -13.09% 57.0883 140.81% 148.6227

Inventory turnover Rate（T）

11.21% 0.366 13.45% 3.1597 13.95% 2.2176 -41.53% 0.7093

Accounts Receivable Turnover Rate（T）

12.86% 0.644 12.77% 6.1309 15.06% 4.7295 -58.47% 1.2111

Current Assets Turnover Rate（T）

12.50% 0.1377 12.48% 1.239 4.40% 0.922 -56.16% 0.262

Total Assets Turnover Rate（T）

43.60% 0.0988 18.04% 0.884 11.95% 0.6681 -62.93% 0.1474

Fixed Assets Turnover Rate（T）

-- -- -0.03% 11.3318 -- -- -61.84% 2.1882

Equity Turnover Rate（T）

56.45% 0.1721 15.91% 1.6046 11.85% 1.2093 -67.24% 0.2364

Cash Position

Free Cash Flow

-440.47% -529.23M 94.27% 1.78B 125.93% 1.08B -47.30% 221.98M

Net Profit Cash Cover

-1,160.97% -420.635% 56.04% 124.389% 13.98% 76.284% 0.91% 61.827%

Operating Revenue Cash Cover

-20.60% 89.996% 2.81% 106.130% 1.83% 100.625% 6.49% 107.449%

Operating Cash In To Assets

-2,449.81% -4.849% 64.05% 27.316% 48.99% 18.293% -91.12% 0.668%

Dividend Ability

Dividend Per Share

-- -- 823.08% 0.6 -- -- -- --

Dividend Cover（T）

-- -- -87.63% 3.1462 -- -- -- --

Cash Dividend Cover（T）

-- -- -78.38% 6.9792 -- -- -- --

Dividend Paid Ratio

-- -- 708.54% 31.785% -- -- -- --

Retained Earning Ratio

0.00% 100.000% -28.99% 68.215% 0.00% 100.000% 0.00% 100.000%

Capital Structure

Debt Assets Ratio

25.01% 28.435% 28.12% 33.599% -1.69% 23.618% -6.16% 23.737%

Current Assets To Total Assets

79.40% 70.312% 5.84% 73.133% 9.74% 75.022% -40.60% 39.405%

Non Current Assets To Total Assets

-51.18% 29.688% -13.06% 26.867% -21.04% 24.978% 80.03% 60.595%

Fix Assets Ratio

-- -- 36.98% 8.856% -- -- -0.09% 7.088%

Interest Bearing Debt To Total Capital

-22.24% 12.977% -11.64% 12.524% -19.74% 10.610% 23.04% 16.937%

Yield Quality

Net Income From Value Changes To Total Profit

-- 6.029% 257.60% 0.189% -- 0.000% -- 0.000%

Recurrent Net Profit To Net Profit

-24.60% 49.541% -10.96% 55.006% -2.94% 61.317% 6.05% 67.611%

Dupont Analysis

Equity Multipler_DuPont

8.96% 1.741% -1.80% 1.815% -0.09% 1.810% -11.63% 1.604%

Net Profit of Parent Company OwnersTo Net Profit_DuPont

-19.57% 56.354% -10.73% 56.074% -3.03% 61.699% 8.50% 70.101%

Net Profit To Total Operating Revenue_DuPont

54.20% 11.664% -10.93% 24.841% 16.76% 35.892% -76.26% 7.336%

Net Profit To Total Profit_DuPont

4.02% 83.522% 1.40% 83.836% 1.57% 84.946% -4.77% 78.765%

Total Profit To EBIT_DuPont

9.22% 89.069% 1.03% 100.209% 5.86% 103.882% -15.37% 84.033%

EBIT To Total Operating Revenue_DuPont

35.74% 15.678% -13.05% 29.568% 8.59% 40.674% -70.54% 11.083%

Currency Unit

CNYCNYCNYCNY

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Research, production and operation of biochemical reagents, clinical diagnostic reagents, medical devices, veterinary injections, biochemical reagent testing tools, genetically-engineered drugs, microbiological environmentally friendly products, leasing of own equipment and related technical services, and is engaged in the import and export of goods and technology import and export business (except for goods and technology restricted to or prohibited by the country).

CEO： --

Market： --

Listing Date： 07/21/2004

Futu Hot List

CNHKUS

SearchNews

SymbolLatest price%Chg

Watchlist